BTK and hemolytic-uremic syndrome: To examine, whether inhibition of BTK affects other organs involved in the triggered immune cell activation and recruitment, we analyzed the activation status of splenic BTK and its direct downstream target PLCγ2 (43, 44) and observed a reduced activation of both proteins in splenic tissue by BTKi in mice with HUS.